Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 73 of 83 for:    CARBAMAZEPINE AND Cytochrome P-450 CYP3A Inducers

Second-Line Treatment Choice for Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00208520
Recruitment Status : Unknown
Verified September 2006 by Dutch Epilepsy Clinics Foundation.
Recruitment status was:  Active, not recruiting
First Posted : September 21, 2005
Last Update Posted : September 12, 2006
Sponsor:
Information provided by:
Dutch Epilepsy Clinics Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : June 2007